Previous Close | 11.00 |
Open | N/A |
Bid | 9.00 |
Ask | 16.90 |
Strike | 840.00 |
Expire Date | 2025-02-21 |
Day's Range | 11.00 - 11.00 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
The transaction was documented in an SEC Filing. Following this transaction, the insider now owns 17,882 shares of Regeneron Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
The fact that multiple Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) insiders offloaded a considerable amount of...
Regeneron (REGN) gets positive CHMP recommendation for odronextamab for the treatment of adults with relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma.